img

Global Anticholinergic Travel Sickness Drugs Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 95 | Industry : Pharma & Healthcare

Publisher : QY | Format : PDF

Global Anticholinergic Travel Sickness Drugs Market Research Report 2024

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Adults
Children


Segment by Application


Hospitals
Drugstores
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E




By Company


GlaxoSmithKline
Baxter International

Table of Content

1 Anticholinergic Travel Sickness Drugs Market Overview
1.1 Product Overview and Scope of Anticholinergic Travel Sickness Drugs
1.2 Anticholinergic Travel Sickness Drugs Segment by Type
1.2.1 Global Anticholinergic Travel Sickness Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Adults
1.2.3 Children
1.3 Anticholinergic Travel Sickness Drugs Segment by Application
1.3.1 Anticholinergic Travel Sickness Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Other
1.4 Global Anticholinergic Travel Sickness Drugs Market Size Estimates and Forecasts
1.4.1 Global Anticholinergic Travel Sickness Drugs Revenue 2016-2027
1.4.2 Global Anticholinergic Travel Sickness Drugs Sales 2016-2027
1.4.3 Anticholinergic Travel Sickness Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Anticholinergic Travel Sickness Drugs Market Competition by Manufacturers
2.1 Global Anticholinergic Travel Sickness Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Anticholinergic Travel Sickness Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Anticholinergic Travel Sickness Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Anticholinergic Travel Sickness Drugs Manufacturing Sites, Area Served, Product Type
2.5 Anticholinergic Travel Sickness Drugs Market Competitive Situation and Trends
2.5.1 Anticholinergic Travel Sickness Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anticholinergic Travel Sickness Drugs Players Market Share by Revenue
2.5.3 Global Anticholinergic Travel Sickness Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Anticholinergic Travel Sickness Drugs Retrospective Market Scenario by Region
3.1 Global Anticholinergic Travel Sickness Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Anticholinergic Travel Sickness Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Anticholinergic Travel Sickness Drugs Market Facts & Figures by Country
3.3.1 North America Anticholinergic Travel Sickness Drugs Sales by Country
3.3.2 North America Anticholinergic Travel Sickness Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anticholinergic Travel Sickness Drugs Market Facts & Figures by Country
3.4.1 Europe Anticholinergic Travel Sickness Drugs Sales by Country
3.4.2 Europe Anticholinergic Travel Sickness Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anticholinergic Travel Sickness Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Anticholinergic Travel Sickness Drugs Sales by Region
3.5.2 Asia Pacific Anticholinergic Travel Sickness Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anticholinergic Travel Sickness Drugs Market Facts & Figures by Country
3.6.1 Latin America Anticholinergic Travel Sickness Drugs Sales by Country
3.6.2 Latin America Anticholinergic Travel Sickness Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anticholinergic Travel Sickness Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Anticholinergic Travel Sickness Drugs Sales by Country
3.7.2 Middle East and Africa Anticholinergic Travel Sickness Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Anticholinergic Travel Sickness Drugs Historic Market Analysis by Type
4.1 Global Anticholinergic Travel Sickness Drugs Sales Market Share by Type (2016-2021)
4.2 Global Anticholinergic Travel Sickness Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Anticholinergic Travel Sickness Drugs Price by Type (2016-2021)

5 Global Anticholinergic Travel Sickness Drugs Historic Market Analysis by Application
5.1 Global Anticholinergic Travel Sickness Drugs Sales Market Share by Application (2016-2021)
5.2 Global Anticholinergic Travel Sickness Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Anticholinergic Travel Sickness Drugs Price by Application (2016-2021)

6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Anticholinergic Travel Sickness Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GlaxoSmithKline Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Baxter International
6.2.1 Baxter International Corporation Information
6.2.2 Baxter International Description and Business Overview
6.2.3 Baxter International Anticholinergic Travel Sickness Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Baxter International Product Portfolio
6.2.5 Baxter International Recent Developments/Updates

7 Anticholinergic Travel Sickness Drugs Manufacturing Cost Analysis
7.1 Anticholinergic Travel Sickness Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anticholinergic Travel Sickness Drugs
7.4 Anticholinergic Travel Sickness Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anticholinergic Travel Sickness Drugs Distributors List
8.3 Anticholinergic Travel Sickness Drugs Customers

9 Anticholinergic Travel Sickness Drugs Market Dynamics
9.1 Anticholinergic Travel Sickness Drugs Industry Trends
9.2 Anticholinergic Travel Sickness Drugs Growth Drivers
9.3 Anticholinergic Travel Sickness Drugs Market Challenges
9.4 Anticholinergic Travel Sickness Drugs Market Restraints

10 Global Market Forecast
10.1 Anticholinergic Travel Sickness Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anticholinergic Travel Sickness Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Anticholinergic Travel Sickness Drugs by Type (2022-2027)
10.2 Anticholinergic Travel Sickness Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anticholinergic Travel Sickness Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Anticholinergic Travel Sickness Drugs by Application (2022-2027)
10.3 Anticholinergic Travel Sickness Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anticholinergic Travel Sickness Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Anticholinergic Travel Sickness Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Anticholinergic Travel Sickness Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Anticholinergic Travel Sickness Drugs Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Anticholinergic Travel Sickness Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Anticholinergic Travel Sickness Drugs Covered in This Study
Table 5. Global Anticholinergic Travel Sickness Drugs Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Anticholinergic Travel Sickness Drugs Sales Share by Manufacturers (2016-2021)
Table 7. Global Anticholinergic Travel Sickness Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Anticholinergic Travel Sickness Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Anticholinergic Travel Sickness Drugs Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Anticholinergic Travel Sickness Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Anticholinergic Travel Sickness Drugs Product Type
Table 12. Global Anticholinergic Travel Sickness Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anticholinergic Travel Sickness Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticholinergic Travel Sickness Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anticholinergic Travel Sickness Drugs Sales by Region (2016-2021) & (K Units)
Table 16. Global Anticholinergic Travel Sickness Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Anticholinergic Travel Sickness Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Anticholinergic Travel Sickness Drugs Sales by Country (2016-2021) & (K Units)
Table 19. North America Anticholinergic Travel Sickness Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Anticholinergic Travel Sickness Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Anticholinergic Travel Sickness Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Anticholinergic Travel Sickness Drugs Sales by Country (2016-2021) & (K Units)
Table 23. Europe Anticholinergic Travel Sickness Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Anticholinergic Travel Sickness Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Anticholinergic Travel Sickness Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Anticholinergic Travel Sickness Drugs Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Anticholinergic Travel Sickness Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Anticholinergic Travel Sickness Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Anticholinergic Travel Sickness Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Anticholinergic Travel Sickness Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Anticholinergic Travel Sickness Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Anticholinergic Travel Sickness Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Anticholinergic Travel Sickness Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Anticholinergic Travel Sickness Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Anticholinergic Travel Sickness Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Anticholinergic Travel Sickness Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Anticholinergic Travel Sickness Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Anticholinergic Travel Sickness Drugs Sales (K Units) by Type (2016-2021)
Table 39. Global Anticholinergic Travel Sickness Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Anticholinergic Travel Sickness Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Anticholinergic Travel Sickness Drugs Revenue Share by Type (2016-2021)
Table 42. Global Anticholinergic Travel Sickness Drugs Price (USD/Unit) by Type (2016-2021)
Table 43. Global Anticholinergic Travel Sickness Drugs Sales (K Units) by Application (2016-2021)
Table 44. Global Anticholinergic Travel Sickness Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Anticholinergic Travel Sickness Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Anticholinergic Travel Sickness Drugs Revenue Share by Application (2016-2021)
Table 47. Global Anticholinergic Travel Sickness Drugs Price (USD/Unit) by Application (2016-2021)
Table 48. GlaxoSmithKline Corporation Information
Table 49. GlaxoSmithKline Description and Business Overview
Table 50. GlaxoSmithKline Anticholinergic Travel Sickness Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. GlaxoSmithKline Anticholinergic Travel Sickness Drugs Product
Table 52. GlaxoSmithKline Recent Developments/Updates
Table 53. Baxter International Corporation Information
Table 54. Baxter International Description and Business Overview
Table 55. Baxter International Anticholinergic Travel Sickness Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Baxter International Anticholinergic Travel Sickness Drugs Product
Table 57. Baxter International Recent Developments/Updates
Table 58. Production Base and Market Concentration Rate of Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Anticholinergic Travel Sickness Drugs Distributors List
Table 61. Anticholinergic Travel Sickness Drugs Customers List
Table 62. Anticholinergic Travel Sickness Drugs Market Trends
Table 63. Anticholinergic Travel Sickness Drugs Growth Drivers
Table 64. Anticholinergic Travel Sickness Drugs Market Restraints
Table 65. Global Anticholinergic Travel Sickness Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 66. Global Anticholinergic Travel Sickness Drugs Sales Market Share Forecast by Type (2022-2027)
Table 67. Global Anticholinergic Travel Sickness Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 68. Global Anticholinergic Travel Sickness Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 69. Global Anticholinergic Travel Sickness Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 70. Global Anticholinergic Travel Sickness Drugs Sales Market Share Forecast by Application (2022-2027)
Table 71. Global Anticholinergic Travel Sickness Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 72. Global Anticholinergic Travel Sickness Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 73. Global Anticholinergic Travel Sickness Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 74. Global Anticholinergic Travel Sickness Drugs Sales Market Share Forecast by Region (2022-2027)
Table 75. Global Anticholinergic Travel Sickness Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 76. Global Anticholinergic Travel Sickness Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anticholinergic Travel Sickness Drugs
Figure 2. Global Anticholinergic Travel Sickness Drugs Market Share by Type in 2020 & 2027
Figure 3. Adults Product Picture
Figure 4. Children Product Picture
Figure 5. Global Anticholinergic Travel Sickness Drugs Market Share by Application in 2020 & 2027
Figure 6. Hospitals
Figure 7. Drugstores
Figure 8. Other
Figure 9. Global Anticholinergic Travel Sickness Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Anticholinergic Travel Sickness Drugs Market Size 2016-2027 (US$ Million)
Figure 11. Global Anticholinergic Travel Sickness Drugs Sales 2016-2027 (K Units)
Figure 12. Global Anticholinergic Travel Sickness Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Anticholinergic Travel Sickness Drugs Sales Share by Manufacturers in 2020
Figure 14. Global Anticholinergic Travel Sickness Drugs Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Anticholinergic Travel Sickness Drugs Players: Market Share by Revenue in 2020
Figure 16. Anticholinergic Travel Sickness Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Anticholinergic Travel Sickness Drugs Sales Market Share by Region (2016-2021)
Figure 18. Global Anticholinergic Travel Sickness Drugs Sales Market Share by Region in 2020
Figure 19. Global Anticholinergic Travel Sickness Drugs Revenue Market Share by Region (2016-2021)
Figure 20. Global Anticholinergic Travel Sickness Drugs Revenue Market Share by Region in 2020
Figure 21. U.S. Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Anticholinergic Travel Sickness Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Anticholinergic Travel Sickness Drugs by Type (2016-2021)
Figure 46. Sales Market Share of Anticholinergic Travel Sickness Drugs by Application (2016-2021)
Figure 47. Sales Market Share of Anticholinergic Travel Sickness Drugs by Application in 2020
Figure 48. Revenue Share of Anticholinergic Travel Sickness Drugs by Application (2016-2021)
Figure 49. Revenue Share of Anticholinergic Travel Sickness Drugs by Application in 2020
Figure 50. Manufacturing Cost Structure of Anticholinergic Travel Sickness Drugs
Figure 51. Manufacturing Process Analysis of Anticholinergic Travel Sickness Drugs
Figure 52. Anticholinergic Travel Sickness Drugs Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed